DESLORATADINE | A078367 | DOCTOR REDDYS LABORATORIES LTD
| Petition | Type | Filed | Status | Petitioner |
|---|---|---|---|---|
Suitability Petition from Lachman Consulting Services, Inc. FDA-2026-P-4918 · 7 docket documents Lachman Consulting Services, Inc., on behalf of a client, filed this suitability petition pursuant to Section 505(j)(2)(C) of the FD&C Act requesting FDA approval to declare Desloratadine Tablets, 2.5 mg suitable for submission as an ANDA with a change in dosage form from the orally disintegrating t | Suitability | 2026-05-06 | Open | Lachman Consulting Services, Inc. |
Source: Regulations.gov. FDA citizen petitions matched by application number.
Highest NADAC/Unit
$4.79
per ea
Lowest NADAC/Unit
$4.79
per ea
Brand NDCs
0
Generic NDCs
2
| NDC Description | NADAC/Unit | Unit | Type | Generic NADAC | Effective |
|---|---|---|---|---|---|
| 55111036006DESLORATADINE 5 MG ODT | $4.79 | EA | Generic | — | 2026-08-19 |
| 55111036031DESLORATADINE 5 MG ODT | $4.79 | EA | Generic | — | 2026-08-19 |
Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.
No patent or exclusivity listings for this strength.